Results: 4

Carnitine analysis in pterygium

Arq. bras. oftalmol; 83 (1), 2020
ABSTRACT Purpose: The aim of the present study was to measure the free carnitine and acylcarnitine levels in pterygium tissue and normal conjunctival tissue at the metabolomics level using tandem mass spectrometry. Methods: In this prospective, clinical randomized study, pterygium tissues and normal co...

Mechanisms and biomarker candidates in pterygium development

Arq. bras. oftalmol; 82 (6), 2019
ABSTRACT Pterygium pathogenesis has been mainly asso ciated with UV light exposure; however, this association remains quite controversial. The complete mechanism of pterygium also remains to be clarified. Factors such as inflammation, viral infection, oxidative stress, DNA methylation, inflammatory media...

Expression of specificity protein 1 and collagen I in primary pterygial tissues

Arq. bras. oftalmol; 82 (5), 2019
ABSTRACT Purpose: To determine the expression profiles of the transcription factor specificity protein 1 and collagen I in primary pterygial and normal conjunctival tissues, and to explore the role of specificity protein 1 and collagen I in pterygial development. Methods: The pterygial tissues of 20 pa...

An investigation of human beta-defensins and cathelicidin expression in patients with pterygium

Arq. bras. oftalmol; 80 (5), 2017
ABSTRACT Purpose: To investigate human beta-defensins (HBDs) and cathelicidin LL-37 (LL-37) expressions in patients with pterygium. Methods: In this retrospective consecutive case series, 26 pterygium specimens and 15 normal conjunctival specimens of 15 control subjects were in vestigated. Expressions ...